A new methodology called Receptorchem offers a promising pathway for specific therapeutic delivery. It copyrights on designing compounds that specifically bind to antigens found on cancerous cells. Unlike traditional methods, Receptorchem strives to reduce undesired effects and enhance clinical e… Read More